Point-of-Care Infectious Disease Diagnostics Testing Market to Reach USD 18.1 Billion by 2033, Driven by Rising Disease Burden and Advances in Rapid Testing

The latest report titled Global Point Of Care Infectious Disease Diagnostics Testing Market contains an in-depth analysis of the fundamental parameters contributing to the global Point Of Care Infectious Disease Diagnostics Testing market scenario. This research report offers readers an in-depth interpretation of the dynamics of the Point Of Care Infectious Disease Diagnostics Testing market, including key drivers, opportunities, threats, and challenges. The report also briefly discusses key business strategies, supply-demand ratios, key regions, prominent market players, and offers a future outlook for the overall Point Of Care Infectious Disease Diagnostics Testing industry.

The global Point-of-Care (POC) Infectious Disease Diagnostics Testing Market is projected to grow from USD 12.2 billion in 2024 to USD 18.1 billion by 2033, registering a compound annual growth rate (CAGR) of 4.50%. This growth is being driven by the rising global incidence of infectious diseases, such as HIV/AIDS, tuberculosis, malaria, and influenza, and the increasing demand for faster, more accessible diagnostic solutions.

You Can Download Free Sample PDF Copy Of This Report At https://www.emergenresearch.com/request-sample/4613

According to the World Health Organization (WHO), infectious diseases account for nearly 30% of annual global deaths. In 2021 alone, tuberculosis caused approximately 1.6 million deaths worldwide, while around 38.4 million people were living with HIV, with 1.5 million new cases reported annually. These staggering numbers underline the urgent need for rapid, on-the-spot diagnostic tools that can help detect infections early and limit their spread.

Efforts from global organizations, such as the WHO's End TB Strategy, are pushing for the use of POC testing in lower-income and remote settings. In the U.S., public health agencies have also increased the use of POC technologies to improve access to timely diagnosis and treatment, especially during outbreaks.

One key advantage of POC testing is its ability to deliver real-time results at the patient's location. This helps ensure faster treatment, reduces the spread of disease, and improves health outcomes-especially in areas where access to healthcare facilities is limited. Technological advances, such as molecular diagnostic platforms that can identify multiple pathogens at once, are playing a vital role in the rising adoption of POC testing.

Technology Driving Market Growth

Molecular diagnostics are emerging as a major driver of growth in the POC testing market. Unlike traditional lab-based testing, molecular POC tests offer fast, accurate, and sensitive results without the need for central labs. Devices like the GeneXpert system, used globally to detect diseases like tuberculosis, are already in use in many low-resource settings and have received support from major health bodies including WHO.

Support for these technologies is growing. For instance, the U.S. National Institutes of Health (NIH) and other public health organizations have invested significantly in the development of molecular POC platforms, especially during the COVID-19 pandemic. These tools have proven essential for quickly identifying infections and preventing further spread, which is critical in pandemic or outbreak situations.

Request Customization: https://www.emergenresearch.com/request-for-customization/4613

Competitive Terrain:

The global Point Of Care Infectious Disease Diagnostics Testing industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

Some major companies included in the Point Of Care Infectious Disease Diagnostics Testing market report are:

Abbott

Thermo Fisher Scientific Inc

F. Hoffmann-La Roche Ltd

Siemens Healthineers

Becton, Dickinson & Company

Chembio Diagnostics Inc.

Trinity Biotech

Cardinal Health

Quest Diagnostics Incorporated

Bio-Rad Laboratories Inc.

bioMérieux SA

Sight Diagnostics Ltd.

The report further divides the Point Of Care Infectious Disease Diagnostics Testing market into key segments such as types, applications, end-user industries, technologies, and key regions of the market. The report also sheds light on the segment and region exhibiting promising growth in the Point Of Care Infectious Disease Diagnostics Testing market.

Point Of Care Infectious Disease Diagnostics Testing Market Segmentation Analysis

By Technology Outlook (Revenue, USD Billion; 2020-2033)

Lateral Flow Immunoassay

Agglutination Test

Flow-through test/Immunoconcentration Assay

Molecular Diagnostics

Others

By Disease Outlook (Revenue, USD Billion; 2020-2033)

HIV POC

Clostridium Difficile POC

HBV POC

Pneumonia Or Streptococcus Associated Infections

Respiratory Syncytial Virus (RSV) POC

HPV POC

Influenza/Flu POC

HCV POC

MRSA POC

TB & Drug-resistant TB POC

HSV POC

COVID-19

Other Infectious Diseases

By End-user Outlook (Revenue, USD Billion; 2020-2033)

Clinics

Hospitals

Home

Assisted Living Healthcare Facilities

Laboratory

Browse Full Report: https://www.emergenresearch.com/industry-report/point-of-care-infectious-disease-diagnostics-testing-market

Regional Outlook:

North America (the U.S., Canada, Mexico)

Europe (the U.K., Germany, France, Italy)

Asia Pacific (India, China, Japan, Korea)

Latin America (Brazil, Argentina, Ecuador, Chile)

Middle East & Africa (Egypt, Turkey, Saudi Arabia, Iran)

Key Questions Answered by the Report:

Which region is expected to dominate the market in the coming years?

What are the recent technological and product advancements occurring in the market?

What are the key strategies adopted by the prominent players in the Point Of Care Infectious Disease Diagnostics Testing market?

What are the key product types and applications of the Point Of Care Infectious Disease Diagnostics Testing industry?

What is the outcome of SWOT analysis and Porter's Five Forces analysis?

How is the competitive landscape of the Point Of Care Infectious Disease Diagnostics Testing market?

Who are the key players in the industry?

What is the growth rate of the industry over the coming years?

What will be the valuation of the Point Of Care Infectious Disease Diagnostics Testing Market by 2033?

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.